Assessing Healthcare Realty Trust’s Valuation After Record Leasing And Raised 2026 Guidance

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

Healthcare Realty Trust (HR) kicked off 2026 with record leasing of over 2 million square feet and nearly 7% same-store NOI growth, which prompted higher full year normalized FFO and NOI guidance alongside active capital deployment.

See our latest analysis for Healthcare Realty Trust.

The strong Q1 leasing update and higher 2026 guidance arrive alongside firm share price momentum. A 16.53% 3 month share price return and a 35.90% 1 year total shareholder return from a US$19.25 starting point help offset a weaker 5 year total shareholder return of 17.36%.

If Q1 leasing strength has you rethinking where healthcare fits in your portfolio, it can be useful to compare this backdrop with other real estate heavy medical technology plays using our screener for 33 healthcare AI stocks

With record Q1 leasing, higher 2026 guidance, a recent US$19.25 share price and an intrinsic value estimate suggesting a 35% discount, you have to ask: is there still an opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 0% Overvalued

Compared with the last close of $19.25, the most followed narrative puts Healthcare Realty Trust's fair value at about $19.18, creating only a very small gap between price and modeled value while still assuming meaningful changes in the business over time.

Balance sheet strengthening via significant asset dispositions (focused on non core, low growth properties), targeted deleveraging, and a right sized dividend increases financial flexibility for reinvestment, positioning the company for improved net margins, earnings quality, and greater capital deployment into high return projects.

Read the complete narrative.

Want to see what has to change for an unprofitable REIT to support that valuation? Revenue, margins, and reinvestment are all pushed in specific directions, and the discount rate quietly holds it together.

The most followed narrative is built on a detailed model that links gradual revenue growth, a shift from a loss of $248.5m toward modest earnings, and an eventual profit margin just above breakeven. It also assumes that share count edges lower and that investors are willing to accept a very large forward P/E multiple in return for that earnings profile, all discounted back at 7.97% to reach a fair value of $19.18 per share.

Result: Fair Value of $19.18 (ABOUT RIGHT)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still clear pressure points, including high leverage and execution risk around asset upgrades and lease up, which could quickly challenge this optimistic setup.

Story Continues

Find out about the key risks to this Healthcare Realty Trust narrative.

Another Lens: Cash Flows Point to Undervaluation

While the consensus narrative clusters around a fair value of about $19.18 per share, the Simply Wall St DCF model presents a different view. On that cash flow based view, Healthcare Realty Trust at $19.25 is shown as trading about 35% below an estimated value of $29.76.

That is a wide gap for you to weigh, especially when the company is still unprofitable and relies on higher risk funding sources. The key question is whether the long term cash flow assumptions in the DCF appear realistic enough to bridge that distance, or whether the market is appropriately skeptical.

Look into how the SWS DCF model arrives at its fair value.HR Discounted Cash Flow as at May 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Healthcare Realty Trust for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With both upside potential and clear risks in view, do not wait for consensus to form. Check the data yourself and weigh the 1 key reward and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that fit your goals, risk comfort, and income needs across the wider market.

Target potential mispricings by scanning 51 high quality undervalued stocks that pair quality fundamentals with discounted valuations. Strengthen your income stream by reviewing 13 dividend fortresses focused on higher yielding companies with resilient payouts. Dial down risk by filtering for 71 resilient stocks with low risk scores that prioritize steadier financial and volatility profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments